Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency

Abstract

Alpha-1-antitrypsin deficiency (AATD) is associated with variable development of emphysema and other features of chronic obstructive pulmonary disease (COPD). Matrix metalloproteinases (MMPs) are believed to be important in the pathophysiology of COPD, and may therefore confer susceptibility to this phenotype in patients with AATD.

Objectives: to assess the role of polymorphism of MMP1, MMP3 and MMP12 in AATD phenotypes.

Methods: 424 PiZZ subjects from the UK AATD Registry were assessed for history of chronic bronchitis (CB), post-bronchodilator lung function impairment and decline of lung function. Tag single nucleotide polymorphisms (SNPs) for MMP1, MMP3 and MMP12 were chosen using HapMap (r²>0.8, MAF>0.05) and were genotyped using TaqMan^® genotyping technologies. Quantitative genetic association was assessed using regression modelling to correct for covariates.

Results: in patients with AATD, carriers of the G allele of rs678815 (MMP3) had lower gas transfer (KCO) (P = 0.025, B =-7.766) than the homozygous wild type, while carriers of the T allele of rs470358 (MMP1) had higher KCO (P = 0.025, B = 6.130).

Conclusions: variations in MMP1 and MMP3 are associated with gas transfer in AATD, supporting a previous family study showing linkage of KCO to this gene region. Replication of these preliminary data is now required particularly if MMP inhibitors are to be considered as a therapeutic option.

Keywords

matrix-metalloproteinase alpha-1-antitrypsin chronic obstructive pulmonary disease genotyping

References

ATS (1996) Cigarette smoking and health, Am J Resp Crit Care Med 153: 861-865.

Barrett, J.C. , Fry, B. , Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps, Bioinformatics 21(2): 263-265.

Belvisi, M.G. and Bottomley, K.M. (2003) The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? Inflamm Res 52: 95-100.

Betsuyaku, T. , Nishimura, M. , Takeyabu, K. , Tanino, M. , Venge, P. , Xu, S. et al. (1999) Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema, Am J Respir Crit Care Med 159: 1985-1991.

Bruce, C. and Thomas, P.S. (2005) The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity, Toxicol Appl Pharmacol 205: 126-132.

Churg, A. , Wang, X. , Wang, R.D. , Meixner, S.C. , Pryzdial, E.L. and Wright, J.L. (2007) Alpha-1-antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages, Am J Respir Cell Mol Biol 37: 144-151.

D'Armiento, J. , Dalal, S.S. , Okada, Y. , Berg, R.A. and Chada, K. (1992) Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema, Cell 71: 955-961.

Decramer, M. , Rutten-van Molken, M. , Dekhuijzen, P.N. , Troosters, T. , van Herwaarden, C. , Pellegrino, R. et al. (2005) Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial, Lancet 365: 1552-1560.

DeMeo, D.L. , Campbell, E.J. , Barker, A.F. , Brantly, M.L. , Eden, E. , McElvaney, N.G. et al. (2008) IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency, Am J Respir Cell Mol Biol 38: 114-120.

10.

DeMeo, D.L. , Hersh, C.P. , Hoffman, E.A. , Litonjua, A.A. , Lazarus, R. , Sparrow, D. et al. (2007) Genetic determinants of emphysema distribution in the national emphysema treatment trial, Am J Respir Crit Care Med 176: 42-48.

11.

DeMeo, D.L. and Silverman, E.K. (2004) Alpha-1-antitrypsin deficency: phenotypes and genetic modifers of emphysema risk, Thorax 59: 259-264.

12.

Dowson, L.J. , Guest, P.J. , Hill, S.L. , Holder, R.L. and Stockley, R.A. (2001) High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health status , Eur Respir J 17: 1097-1104.

13.

Elston, R.C. and Ann Spence, M. (2006) Advances in statistical human genetics over the last 25 years, Statist Med 25: 3049-3080.

14.

Finlay, G.A. , Russell, K.J. , McMahon, M. , D' Arcy, E. , Masterson, J.B. , FitzGerald, M.X. et al. (1997) Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients, Thorax 52: 502-506.

15.

Fletcher, C. and Peto, R. (1977) The natural history of chronic airflow obstruction , Br Med 1(6077): 1645-1648.

16.

Golub, L.M. , Lee, H.M. , Ryan, M.E. , Giannobile, W.V. , Payne, J. and Sorsa, T. (1998) Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms, Adv Dent Res 12: 12-26.

17.

Gottlieb, D.J. , Sparrow, D. , Gale, M.E. , Weiss, S.T. , Snider, G.L. and O'Conner, G.T. (1996) Urinary desmosine excretion in smokers with and without rapid decline of lung function: the normal aging study, Am J Resp Crit Care Med 154: 1290-1295.

18.

Harel, S. , Janoff, A. , Yu, S.Y. , Hurewitz, A. and Bergofsky, E.H. (1980) Desmosine radioimmunoassay for measuring elastin degradation in vitro, Rev Respir Dis 122: 769-773.

19.

Hautamaki, R.D. , Kobayashi, D.K. , Senior, R.M. and Shapiro, S.D. (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice, Science 277: 2002-2004.

20.

Hersh, C.P. , Demeo, D.L. , Lange, C. , Litonjua, A.A. , Reilly, J.J. , Kwiatkowski, D. et al. (2005) Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations, Am J Respir Cell Mol Biol 33: 71-78.

21.

Hill, A.T. , Campbell, E.J. , Bayley, D.L. , Hill, S.L. and Stockley, R.A. (1999) Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ), Am J Respir Crit Care Med 160: 1968-1975.

22.

Holme, J. , Stockley, J.A. and Stockley, R.A. (2007) When should we start monitoring alpha 1 antitrypsin deficient subjects? Thorax 62: A140.

23.

Holme, J. and Stockley, R.A. (2007) Radiologic and clinical features of COPD patients with discordant pulmonary physiology: lessons from alpha1-antitrypsin deficiency , Chest 132: 909-915.

24.

International HapMap Consortium (2005) A haplotype map of the human genome, Nature 437: 1299-1320.

25.

Joos, L. , He, J.Q. , Shepherdson, M.B. , Connett, J.E. , Anthonisen, N.R. , Pare, P.D. et al. (2002) The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function, Hum Mol Genet 11: 569-576.

26.

Ma, S. , Lin, Y.Y. and Turino, G.M. (2007) Measurements of desmosine and isodesmosine by mass spectrometry in COPD, Chest 131: 1363-1371.

27.

Muller, N.L. , Staples, C.A. , Miller, R.R. and Abboud, R.T. (1988) 'Density mask'. An objective method to quantitate emphysema using computed tomography, Chest 94: 782-787.

28.

Nagase, H. and Woessner, J. (1999) Matrix metalloproteinases, J Bio Chem 274: 21491-21494.

29.

Needham, M. and Stockley, R.A. (2004) Alpha-1-antitrypsin deficiency: clinical manifestations and natural history, Thorax 59: 441-445.

30.

Newby, P.R. , Roberts-Davies, E.L. , Brand, O.J. , Heward, J.M. , Franklyn, J.A. , Gough, S.C. et al. (2007) Tag SNP screening of the PDCD1 gene for association with Graves' disease, Clin Endocrinol (Oxf) 67: 125-128.

31.

Parr, D.G. , Stoel, B.C. , Stolk, J. and Stockley, R.A. (2004) Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment, Am J Respir Crit Care Med 170(11): 1172-1178.

32.

Pendas, A.M. , Santamaria, I. , Alvarez, M.V. , Pritchard, M. and Lopez-Otin, C. (1996) Fine physical mapping of the human matrix metalloproteinase genes clustered 11q22.3, Genomics 37: 266-282.

33.

Rennard, S.I. , Fogarty, C. , Kelsen, S. , Long, W. , Ramsdell, J. , Allison, J. et al. (2007) The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease, Am J Respir Crit Care Med 175: 926-934.

34.

Rutter, J.L. , Mitchell, T.I. , Buttice, G. , Meyers, J. , Gusella, J.F. , Ozelius, L.J. et al. (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription, Cancer Res 58: 5321-5325.

35.

Seitz, M. , Wirthmuller, U. , Moller, B. and Villiger, P.M. (2007) The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients, Rheumatology ( Oxford) 46: 93-96.

36.

Soejima, K. , Yamaguchi, K. , Kohda, E. , Takeshita, K. , Ito, Y. , Mastubara, H. et al. (2000) Longitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomography, Am J Respir Crit Care Med 161: 1264-1273.

37.

Stockley, R.A. (1999) Neutrophils and protease/ antiprotease imbalance , Am J Respir Crit Care Med 160: S49-52.

38.

Stockley, R.A. and Luisetti, M. (eds) (1999) Alpha-1-Antitrypsin Deficiency: The Biochemical Basis of Pulmonary Emphysema. Pavia: IRCCS.

39.

Stolk, J. (2007) Identification of genetic modifiers of emphysema in phenotypically discordant PiZZ alpha 1 antitrypsin deficient patients. Personal communication, ERS, Stockholm.

40.

Tsukahara, S. , Shinozaki, M. , Ikari, K. , Mochizuki, T. , Inoue, E. , Tomatsu, T. et al. (2008) Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients, Rheumatology (Oxford) 47: 41-44.

41.

Wood, A.M. , McNab, G.L. and Stockley, R.A. (2007a) A polymorphism in the matrix metalloproteinase 9 gene may influence emphysema distribution in alpha 1 anti-trypsin deficiency , British Thoracic Society London 62: A115.

42.

Wood, A.M. , Simmonds, M.J. , Newby, P.R. , Gough, S.C. and Stockley, R.A. (2007b) Variation in the surfactant protein B gene is associated with development of airflow obstruction in alpha 1 anti-trypsin deficiency, British Thoracic Society London 62: A29.

43.

Wood, A.M. and Stockley, R.A. (2006) The genetics of chronic obstructive pulmonary disease , Respir Res 7: 130.

44.

Wtccc (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature 447: 661-678.